ReviewCancer drug resistance (Alhambra, Calif.)2019

Resistance to cis- and carboplatin initiated by epigenetic changes in ovarian cancer patients.

Heidi Schwarzenbach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.